Net profit of Supriya Lifescience rose 93.26% to Rs 46.15 crore in the quarter ended September 2024 as against Rs 23.88 crore during the previous quarter ended September 2023. Sales rose 18.56% to Rs 166.10 crore in the quarter ended September 2024 as against Rs 140.10 crore during the previous quarter ended September 2023.
Particulars | Quarter Ended |
| Sep. 2024 | Sep. 2023 | % Var. |
Sales | 166.10 | 140.10 | 19 |
OPM % | 38.96 | 22.66 | - |
PBDT | 66.81 | 33.76 | 98 |
PBT | 62.07 | 29.78 | 108 |
NP | 46.15 | 23.88 | 93 |